Taro Pharmaceutical Industries Ltd reports results for the quarter ended in September - Earnings Summary

Taro Pharmaceutical Industries

27/10/2023 24:09

* Taro Pharmaceutical Industries Ltd  TARO.N  reported
quarterly
adjusted earnings of 38 cents​​ per share for the quarter ended
in September. The lone analyst forecast for the quarter was
for earnings of 18 cents per share.
    * Revenue rose 13.6% to $148.20 million from a year ago;
analysts
expected $161.14 million. 
    * Taro Pharmaceutical Industries Ltd's reported EPS for the
quarter was 23 cents​.
    * The mean earnings estimate of analysts had fallen by
about 40%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Taro Pharmaceutical Industries Ltd shares had fallen
by 10.8%
this quarter and gained 15.9% so far this year.
    * The company reported quarterly net income of $8.55
million.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
October 26 at 11:08 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2023      0.18           0.38           Beat
 Jun. 30 2023      0.31           0.40           Beat
 Mar. 31 2023      0.23           0.18           Missed
 Dec. 31 2022      0.87           0.19           Missed